Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?
Clinical and Translational Allergy · 2023-04 · 13 (4)
DOI: 10.1002/clt2.12247 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Allergy, online erschienen am 23.04.2023. Verfasst von Yin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Otolaryngology-Head and Neck Surgery and Allergy, Central Hospital of Huangshi City, Huangshi, China.
- Department of Allergology, Zhongnan Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Rong-Fei Zhu, Ya-Dong Gao
Zitieren
APA
Wang, Y., Chen, H., Dong, X., Chen, H., Liang, H. L., Yang, Y. Q., Chen, Y. D., Zhu, R. F., & Gao, Y. D. (2023). Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?. Clinical and Translational Allergy, 13(4). https://doi.org/10.1002/clt2.12247
Vancouver
Wang Y, Chen H, Dong X, Chen H, Liang HL, Yang YQ, et al. Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?. Clinical and Translational Allergy. 2023;13(4). doi:10.1002/clt2.12247
BibTeX
@article{Wang2023,
author = {Wang, Yin and Chen, Huan and Dong, Xiang and Chen, Hao and Liang, Hui-Ling and Yang, Ya-Qi and Chen, Yan-Dan and Zhu, Rong-Fei and Gao, Ya-Dong},
title = {Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?},
journal = {Clinical and Translational Allergy},
year = {2023},
volume = {13},
number = {4},
doi = {10.1002/clt2.12247}
}
EUVIMED